Advertisement

International Journal of Hematology

, Volume 76, Issue 4, pp 376–378 | Cite as

Pseudo Gray Platelet Syndrome in a Patient with Acute Myocardial Infarction

  • Shigeo Toyota
  • Norihiko Nakamura
  • Kazuo Dan
Case Report

Abstract

W e report a patient with pseudo gray platelet syndrome. He was admitted to our hospital because of acute myocardial infarction. He had platelets that were stained poorly and appeared gray and agranular under a light microscope. This appear-ance is a characteristic feature of gray platelet syndrome. However, in this case, no bleeding tendency was observed and the abnormality was dependent on the presence of ethylenediamine tetra acetic acid (EDTA) and did not occur in a nonantico-agulant, trisodium citrate dihydrate and heparin. There are few reports of this pseudo gray platelet syndrome and, in fact, this is the first report of the syndrome in Japan, possibly because the phenomenon has been unrecognized and passed over in the past.Int J Hematol. 2002;76:376-378.

Key words

Pseudo gray platelet syndrome EDTA 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Raccuglia G. Grey platelet syndrome: a variety of qualitative platelet disorder.Am J Med. 1971; 51: 818–828.CrossRefPubMedGoogle Scholar
  2. 2.
    Gerrard JM, Phillips DR, Rao GHR, et al. Biochemical studies of two patients with the gray platelet syndrome.J Clin Invest. 1980; 66: 102–109.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    White JG. Ultrastructural studies of the gray platelet syndrome.Am J Pathol. 1979; 95: 455–462.Google Scholar
  4. 4.
    Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome:demonstration of alpha granule membranes that can fuse with the cell surface.J Clin Invest. 1987; 80: 1138–1146.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome.Tohoku J Exp Med. 1984; 143: 261–287.CrossRefPubMedGoogle Scholar
  6. 6.
    Cockbill SR, Burmester HBC, Heptinstall S. Pseudo grey platelet syndrome-grey platelets due to degranulation in blood collected into EDTA.Eur J Haematol. 1988; 41: 326–333.CrossRefPubMedGoogle Scholar
  7. 7.
    Stavem P, Berg K. A macromolecular serum component acting on platelets in the presence of EDTA- ’platelet stain preventing factor.’Scand J Haematol. 1973; 10: 202–208.CrossRefPubMedGoogle Scholar
  8. 8.
    Mant MJ, Doery JCG, Gauldie J, Sims H. Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA.Scand J Haematol. 1975; 15: 161–170.CrossRefPubMedGoogle Scholar
  9. 9.
    Onder O, Weinstein A, Hoyer LW. Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents.Blood. 1980; 56: 177–182PubMedGoogle Scholar
  10. 10.
    Bizzaro N. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up.Am J Hematol. 1995; 50: 103–109.CrossRefPubMedGoogle Scholar
  11. 11.
    Hoyt RH, Durie BG. Pseudothrombocytopenia induced by a monoclonal IgM kappa platelet agglutinin.Am J Hematol. 1989; 31: 50–52.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Shigeo Toyota
    • 1
  • Norihiko Nakamura
    • 2
  • Kazuo Dan
  1. 1.Department of Internal MedicineYokosuka Kyousai HospitalYokosuka, KanagawaJapan
  2. 2.Third Department of Internal MedicineNippon Medical SchoolTokyoJapan

Personalised recommendations